Cancer Testis Antigen (CTA) T21, As a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours. joms 2022, 17 (1), 1-7. https://doi.org/10.51984/joms.v17i1.1892.